Loading…
Patient Access to ESRD New Innovative Devices Act
Legislative Progress
Introduced
September 22, 2021
Latest Action
September 23, 2021
Primary Sponsor
Danny K. DavisDemocratic(IL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
43pct
1d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Patient Access to ESRD New Innovative Devices Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to provide a certain payment adjustment under the Medicare end-stage renal disease (ESRD) prospective payment system. Specifically, the CMS must provide for a three-year temporary add-on payment adjustment for new medical devices used to diagnose, treat, or manage ESRD. (CMS regulations currently provide a two-year temporary add-on payment adjustment.)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2022 · fourth_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 5376 (P.L. 117-169), the Inflation Reduction Act. Issues related to safe mobility, including H.Res. 1177. Monitored H.R. 7053/S. 3792, The Hospital Inpatient Services Modernization Act and issues related to extension of the acute hospital care at home program. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to the extension of the Acute Hospital Care at Home program.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
HR3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions. HR19 / S. 2164, Lower Costs, More Cures Act of 2021, all provisions. Legislation to incentivize new technology for innovation in home dialysis (no current bill number). S.2025/H.R.5331, Patient Access to ESRD New Innovative Devices Act, all provisions. Issues relating to innovation in ventilators.
Client expense: $470,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
HR3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions. HR19 / S. 2164, Lower Costs, More Cures Act of 2021, all provisions. Legislation to incentivize new technology for innovation in home dialysis (no current bill number). S.2025/H.R.5331, Patient Access to ESRD New Innovative Devices Act, all provisions. Issues relating to innovation in ventilators.
Client expense: $560,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 5376 (P.L. 117-169), the Inflation Reduction Act. Issues related to safe mobility, including H.Res. 1177. Monitored H.R. 7053/S. 3792, The Hospital Inpatient Services Modernization Act and issues related to extension of the acute hospital care at home program.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Medicare/Medicaid
HR3, Elijah E. Cummings Lower Drug Costs Now Act, all provisions. HR19 / S. 2164, Lower Costs, More Cures Act of 2021, all provisions. Legislation to incentivize new technology for innovation in home dialysis (no current bill number). S.2025/H.R.5331, Patient Access to ESRD New Innovative Devices Act, all provisions. Issues relating to innovation in ventilators.
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Issues related to safe mobility. Monitored H.R. 7053/S. 3792, The Hospital Inpatient Services Modernization Act and issues related to extension of the acute hospital care at home program.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · first_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 5376, The Build Back Better Act. Issues related to safe mobility.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · fourth_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2021 · third_quarter · Medicare/Medicaid
Issues related to ESRD / PPS transitional technology add-on payment adjustment for new and innovative equipment and supplies. Issues regarding dialysis in the home. Issues related to S. 2025 / H.R. 5331, Patient Access to ESRD New Innovative Devices Act. Monitored drug pricing issues related to H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, H.R. 5376, The Build Back Better Act, and H.R. 19/S. 2164, the Lower Costs, More Cures Act.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE